Open AccessBevacizumab + Atezolizumab for Newly Diagnosed Stage III/IV Ovarian Cancer
Author(s) -
Sarah LaCorte
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723528.13093.9c
Subject(s) - bevacizumab , atezolizumab , carboplatin , medicine , oncology , ovarian cancer , paclitaxel , lung cancer , chemotherapy , population , cancer , immunotherapy , pembrolizumab , cisplatin , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom